Benjamin Weide
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
Papers in
- Oncology 40
- Cutaneous Melanoma Detection and Management 17
- Cancer Immunotherapy and Biomarkers 17
- CAR-T cell therapy research 12
- Immunology 27
- Immunotherapy and Immune Responses 21
- Immune Cell Function and Interaction 8
- Immune cells in cancer 4
- Co-authors
- Claus Garbe (55 shared papers)Thomas Eigentler (36 shared papers)Graham Pawelec (14 shared papers)Steve Pascolo (5 shared papers)Annette Pflugfelder (19 shared papers)Birgit Scheel (4 shared papers)Ingmar Hoerr (4 shared papers)Hans‐Georg Rammensee (4 shared papers)
- Journals
- Cancer Immunology Immunotherapy (7 papers)PLoS ONE (6 papers)Journal of Clinical Oncology (6 papers)British Journal of Dermatology (4 papers)Clinical Cancer Research (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Benjamin Weide
73 papers receiving 3.6k citations
Benjamin Weide's Hit Papers
Peers
Comparison fields: 5 of 94
- Immunology 1.8k
- Oncology 1.9k
- Molecular Biology 1.3k
- Dermatology 125
- Cancer Research 186
Countries citing papers authored by Benjamin Weide
This map shows the geographic impact of Benjamin Weide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Weide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Weide more than expected).
Fields of papers citing papers by Benjamin Weide
This network shows the impact of papers produced by Benjamin Weide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Weide. The network helps show where Benjamin Weide may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Weide, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients Hit paper breakdown → | 2015 | 460 |
| 2 | 2009 | 306 | |
| 3 | 2013 | 213 | |
| 4 | 2008 | 207 | |
| 5 | 2007 | 169 | |
| 6 | 2016 | 145 | |
| 7 | 2003 | 144 | |
| 8 | 2011 | 125 | |
| 9 | 2010 | 116 | |
| 10 | 2013 | 99 | |
| 11 | 2015 | 97 | |
| 12 | 2012 | 91 | |
| 13 | 2015 | 82 | |
| 14 | 2014 | 79 | |
| 15 | 2018 | 72 | |
| 16 | 2007 | 68 | |
| 17 | 2000 | 61 | |
| 18 | 2007 | 60 | |
| 19 | 2013 | 53 | |
| 20 | 2019 | 44 |
About Benjamin Weide
Benjamin Weide is a scholar working on Oncology, Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 74 papers that have together received 3.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (21 papers), Cutaneous Melanoma Detection and Management (17 papers), Cancer Immunotherapy and Biomarkers (17 papers), CAR-T cell therapy research (12 papers), Melanoma and MAPK Pathways (11 papers), Immune Cell Function and Interaction (8 papers), RNA Interference and Gene Delivery (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Immunology (1.8k citations), Oncology (1.9k citations), Molecular Biology (1.3k citations), Dermatology (125 citations) and Cancer Research (186 citations). Benjamin Weide has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Claus Garbe, Thomas Eigentler, Graham Pawelec, Steve Pascolo, Annette Pflugfelder, Birgit Scheel, Ingmar Hoerr, Hans‐Georg Rammensee, Evelyna Derhovanessian and Henning Zelba. Their work appears in journals such as Cancer Immunology Immunotherapy, PLoS ONE, Journal of Clinical Oncology, British Journal of Dermatology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.